http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200019979-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a57036e4339d4d44cbb4ccce6c175cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D313-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-83
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
filingDate 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e656eb698ccb4f0c69d964922f8eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d972169b0595ae592e135d5be155db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5419a62fb3e560364cc286b74f11cb92
publicationDate 2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20200019979-A
titleOfInvention α, β unsaturated amide compounds
abstract An object of the present invention is to provide an α, β unsaturated amide compound having a anticancer activity or the like, or a pharmaceutically acceptable salt thereof. Α, β unsaturated amide compounds represented by the following formula (I) or pharmaceutically acceptable salts thereof and the like have anticancer activity and the like: [Wherein, A represents a heterocyclic diyl which may have a substituent, R 1 represents a hydrogen atom or lower alkyl which may have a substituent, and R 2 may have an aryl or substituent which may have a substituent; Cycloalkyl, an aliphatic heterocyclic group which may have a substituent or an aromatic heterocyclic group which may have a substituent, represents X, -O-, -S-, -SO 2- , -NR X1- (wherein, R X1 Represents a hydrogen atom or lower alkyl), -CHR X2- (wherein R X2 represents a hydrogen atom or hydroxy), -CH = CH-, -CO- or -NH-CO-, n1 and n2 are the same or different and represent 0 or 1, respectively.
priorityDate 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9948859-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9809956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005042497-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011022440-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004032909-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015188777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6002008-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009051822-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466277197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466726796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466664500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466664499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467928599

Total number of triples: 76.